Transactions

Our broad-based transaction experience extends across a range of situations, industries and enterprise values

Type

Industry

Canadian National Railway Co.

Announced: May 21, 2021
Value: $33.6 billion
Status: Pending

Financial advisor to CN on its combination with Kansas City Southern

ICON plc

Announced: February 24, 2021
Value: $12 billion
Status: Pending

Lead financial advisor to ICON on its acquisition of PRA Health Sciences

GW Pharmaceuticals PLC

Announced: February 3, 2021
Value: $7.2 billion
Status: Closed

Financial advisor to GW Pharmaceuticals on its sale to Jazz Pharmaceuticals

Walgreens Boots Alliance, Inc.

Announced: January 6, 2021
Value: $6.5 billion
Status: Closed

Exclusive financial adviser to Walgreens Boots Alliance on the sale of its Alliance Healthcare businesses to AmerisourceBergen

Cantel Medical Corp.

Announced: January 12, 2021
Value: $4.6 billion
Status: Closed

Exclusive financial advisor to Cantel on its sale to STERIS plc

Dave, Inc.

Announced: June 7, 2021
Value: $4 billion
Status: Pending

Exclusive financial advisor to Dave on its combination with VPC Impact Acquisition Holdings III, Inc., a special purpose acquisition company sponsored by Victory Park Capital

Aggreko plc

Announced: March 5, 2021
Value: £2.3 billion
Status: Pending

Financial advisor to Aggreko on its sale to a consortium comprised of TDR Capital and I Squared Capital

CAI International, Inc.

Announced: June 17, 2021
Value: $2.9 billion
Status: Pending

Exclusive financial advisor to CAI on its sale to Mitsubishi HC Capital

Summit Utilities, Inc.

Announced: April 29, 2021
Value: $2.15 billion
Status: Pending

Financial advisor to Summit on its acquisition of CenterPoint Energy's Arkansas and Oklahoma natural gas LDC assets

Duke Energy Corporation

Announced: January 28, 2021
Value: $2.05 billion
Status: Pending

Financial advisor to Duke Energy on the sale of a minority interest in Duke Energy Indiana to GIC, the Singapore-based sovereign wealth fund

Mondelez International

Announced: May 26, 2021
Value: $2 billion
Status: Pending

Exclusive financial advisor to Mondelez on its acquisition of Chipita S.A.

Pandion Therapeutics, Inc.

Announced: February 25, 2021
Value: $1.85 billion
Status: Pending

Exclusive financial advisor to Pandion on its sale to Merck

Constellation Pharmaceuticals Inc.

Announced: June 2, 2021
Value: $1.7 billion
Status: Pending

Financial advisor to Constellation on its sale to MorphoSys

Perrigo Company plc

Announced: March 1, 2021
Value: $1.55 billion
Status: Pending

Exclusive financial advisor to Perrigo on the sale of its Generic Prescription Pharmaceuticals business to Altaris

Honeywell International, Inc.

Announced: January 11, 2021
Value: $1.2 billion
Status: Closed

Financial advisor to Honeywell in connection with the resolution of claims with Garrett Motion Inc. in connection with its court-supervised Chapter 11 proceedings

Avantor, Inc.

Announced: April 12, 2021
Value: €890 million
Status: Closed

Financial advisor to Avantor on its acquisition of Ritter GmbH

Aegion Corporation

Announced: April 14, 2021
Value: $1.1 billion
Status: Pending

Exclusive financial advisor to Aegion on its sale to an affiliate of New Mountain Capital

DENTSPLY SIRONA Inc.

Announced: January 4, 2021
Value: $1.04 billion
Status: Closed

Exclusive financial advisor to Dentsply Sirona on its acquisition of Byte

Arvelle Therapeutics

Announced: January 4, 2021
Value: $960 million
Status: Closed

Exclusive financial advisor to Arvelle on its sale to Angelini Pharma

Springstone, Inc.

Announced: June 15, 2021
Value: $950 million
Status: Pending

Lead financial advisor to Welsh, Carson, Anderson & Stowe ("WCAS") and Springstone on its divestiture of 18 inpatient behavioral health hospital facilities and the sale of an interest in Springstone's operations from WCAS to Medical Properties Trust, Inc.

Janus Henderson Group plc

Announced: February 4, 2021
Value: $900 million
Status: Pending

Financial advisor to Janus Henderson in connection with the secondary offering of shares held by Dai-Ichi Life Holdings

Twilio Inc.

Announced: March 1, 2021
Value: Up to $750 million
Status: Pending

Exclusive financial advisor to Twilio on its partnership with Syniverse

Christian Louboutin S.A.

Announced: March 8, 2021
Value: €541 million
Status: Pending

Financial advisor to Christian Louboutin on its sale of a minority stake to Exor

DuPont

Announced: February 1, 2021
Value: $510 million
Status: Pending

Exclusive financial advisor to DuPont on the sale of its Clean Technologies business to an international private equity consortium consisting of BroadPeak Global LP, Asia Green Fund and The Saudi Arabian Industrial Investments Company

Trinseo

Announced: July 20, 2021
Value: $445 million
Status: Pending

Exclusive financial advisor to Trinseo on its acquisition of Aristech Surfaces

Daily Mail and General Trust plc

Announced: February 18, 2021
Value: $410 million
Status: Pending

Exclusive financial adviser to DMGT on the sale of Hobsons, its EdTech business, in two separate transactions to PowerSchool and EAB

Houghton Mifflin Harcourt Company

Announced: March 29, 2021
Value: $349 million
Status: Pending

Exclusive financial advisor to Houghton Mifflin Harcourt on the divestiture of HMH Books & Media, its consumer publishing segment, to News Corp

R1 RCM Inc.

Announced: May 4, 2021
Value: $300 million
Status: Pending

Financial advisor to R1 RCM on its acquisition of VisitPay

Honeywell International Inc.

Announced: January 25, 2021
Value: $230 million
Status: Pending

Exclusive financial advisor to Honeywell on the sale of its lifestyle and performance footwear business (Original Muck Boot, XTRATUF, Ranger, NEOS and Servus) to Rocky Brands, Inc.

Tradeweb Markets Inc.

Announced: February 2, 2021
Value: $190 million
Status: Pending

Exclusive financial advisor to Tradeweb on its acquisition of Nasdaq's U.S. fixed income electronic trading platform

Pacific Biosciences of California, Inc.

Announced: July 20, 2021
Value: Up to $800mm
Status: Pending

Exclusive financial advisor to PacBio on its acquisition of Omniome

Cisco Systems, Inc.

Announced: May 14, 2021
Status: Pending

Financial advisor to Cisco on its acquisition of Kenna Security

Adverum Biotechnologies, Inc.

Announced: May 12, 2021
Status: Closed

Exclusive financial advisor to Adverum on its 2021 shareholder vote

Landmark Health, LLC

Announced: April 23, 2021
Status: Closed

Lead financial advisor to Landmark Health on its sale to UnitedHealth Group

Kohl's Corporation

Announced: April 14, 2021
Status: Closed

Financial advisor to Kohl's in its settlement agreement with Macellum Advisors, Ancora, Legion Partners and 4010 Capital

Leeds Equity Partners

Announced: March 31, 2021
Status: Pending

Financial advisor to Leeds Equity Partners and BARBRI on BARBRI’s sale to Francisco Partners

Triple Lift, Inc.

Announced: March 29, 2021
Status: Pending

Exclusive financial advisor to TripleLift on its receipt of a majority investment from Vista Equity Partners

Exelon Corporation

Announced: February 24, 2021
Status: Pending

Financial advisor to Exelon on the separation of its utility and competitive energy businesses

Reckitt Benckiser Group plc

Announced: February 24, 2021
Status: Pending

Exclusive financial advisor to RB on its acquisition of the Biofreeze and TheraPearl Brands from Performance Health

Reckitt Benckiser Group plc

Announced: February 24, 2021
Status: Pending

Financial advisor to RB on its sale of Scholl to Yellow Wood Partners

MedRisk, Inc.

Announced: February 23, 2021
Status: Closed

Financial advisor to MedRisk and Carlyle on Caryle's sale of MedRisk to CVC Capital Partners

Amphenol Corporation

Announced: January 19, 2021
Status: Pending

Exclusive financial advisor to Amphenol on the sale of the MTS Test & Simulation business to Illinois Tool Works following the closing of Amphenol's acquisition of MTS Systems Corporation

R1 RCM Inc.

Announced: January 6, 2021
Status: Pending

Financial advisor to R1 RCM on its conversion agreement with Ascension and TowerBrook

Mondelez International

Announced: January 5, 2021
Status: Pending

Exclusive advisor to Mondelez on its acquisition of Hu Products

Centerview Partners takes a “One Firm” approach to deliver unmatched intellectual capital and integrity to all of our clients. We have industry-leading expertise in:

At Centerview Partners, our success depends on our people, and we are always looking for talented individuals. Please let us know if you would like to learn more about a career at Centerview.
Our Partners have worked on many of the largest and most complex transactions and corporate situations around the globe over the course of their careers. Learn more about who we are.